NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 245 filers reported holding NEKTAR THERAPEUTICS in Q1 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $4,026,000 | +96.5% | 186,538 | +65.8% | 0.06% | +39.5% |
| Q3 2019 | $2,049,000 | -36.8% | 112,504 | +111.4% | 0.04% | -27.1% |
| Q3 2018 | $3,244,000 | -84.0% | 53,227 | -87.2% | 0.06% | -84.1% |
| Q2 2018 | $20,279,000 | +8833.5% | 415,300 | +19397.7% | 0.37% | +9175.0% |
| Q1 2018 | $227,000 | -70.8% | 2,130 | -83.6% | 0.00% | -60.0% |
| Q4 2017 | $777,000 | +250.0% | 13,007 | -16.7% | 0.01% | +400.0% |
| Q2 2016 | $222,000 | -59.7% | 15,613 | -64.6% | 0.00% | -81.8% |
| Q2 2015 | $551,000 | +135.5% | 44,078 | +192.1% | 0.01% | +10.0% |
| Q4 2014 | $234,000 | -35.4% | 15,092 | -49.7% | 0.01% | -41.2% |
| Q3 2014 | $362,000 | +244.8% | 30,000 | +200.0% | 0.02% | +325.0% |
| Q3 2013 | $105,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIRSCHWELL & LOEWY INC | 588,908 | $7,138,000 | 1.23% |
| Granahan Investment Management | 3,693,956 | $44,771,000 | 1.21% |
| NEA Management Company, LLC | 1,825,600 | $22,126,000 | 1.09% |
| FIC CAPITAL INC | 150,868 | $1,829,000 | 0.75% |
| Rhenman & Partners Asset Management AB | 181,797 | $2,203,000 | 0.66% |
| SOPHROSYNE CAPITAL LLC | 60,200 | $728,000 | 0.64% |
| HARVEY CAPITAL MANAGEMENT INC | 130,400 | $1,580,000 | 0.63% |
| Artal Group S.A. | 1,300,000 | $15,756,000 | 0.57% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 564,418 | $6,840,000 | 0.47% |
| OppenheimerFunds, Inc. | 24,400,000 | $295,728,000 | 0.35% |